GenoSensor Corporation

 

Clinical Applications

Molecular technologies play an important role in evolving medicine. Monitoring genes and their activities can accurately reveal individual health and disease conditions. We develop and market predictive and personalized medicine products. Our technology core focuses on protecting and identifying genes in peripheral blood samples.

TheraLead™, a blood based molecular assay, is available on market via Clinicogen.

GS™ COVID-19 Real-Time PCR Kit provides quick research solutions for 2019 coronavirus disease (COVID-19) and SARS-CoV-2.

The coronavirus disease outbreak began in December 2019. It is spreading rapidly throughout the world, becoming pandemic. GenoSensor has developed a highly sensitive assay that directly detects the viral genome (RNA) using real-time RT-PCR, thus efficiently helping you for your research needs.

 

Cat # Product Name Description

Size

2702
GS™ COVID-19 Real-Time PCR Kit - 30 Provide all-in-one master mix including cDNA synthesis, PCR mix, primers and probe of each gene.
22-96 samples

For research and educational use, read more.

 

For more up-to-date information on the current coronavirus outbreak, visit the WHO or CDC websites.

 

Home | Company Profile | Products & Services | Press Room | Employment | Contact Us